Bosentan in pulmonary arterial hypertension: a comparison between congenital heart disease and chronic pulmonary embolism

Background. In patients with pulmonary hypertension, it is unknown whether the treatment effect of bosentan is dependent on the duration of pulmonary vessel changes. Therefore, we studied the response to bosentan in patients with life-long pulmonary vessel changes (pulmonary arterial hypertension (P...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Duffels, M.G.J., van der Plas, M.N., Surie, S., Winter, M.M., Bouma, B., Groenink, M., van Dijk, A.P.J., Hoendermis, E., Berger, R.M.F., Bresser, P., Mulder, B.J.M.
Médium: Artigo
Jazyk:Inglês
Vydáno: Bohn Stafleu van Loghum 2009
Témata:
Original Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC2758348/
https://ncbi.nlm.nih.gov/pubmed/19949475
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky